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Abstract
Viral zoonoses may represent a serious problem when xenotransplantation using pig cells, 
tissues, and organs will be performed. Recently we reported multiorgan failure, mainly liver 
failure, in a baboon (Papio anubis) after orthotopic transplantation of a heart from a genetically 
modified pig and showed that the baboon was not infected with hepatitis E virus (HEV). Since 
pigs are frequently infected with porcine cytomegalovirus (PCMV), and the infection is latent 
and therefore difficult to detect, screening for PCMV was performed, using a highly sensitive 
real-time PCR and a nested PCR. In addition, to confirm the absence of HEV, more specific 
immunological methods and a real-time PCR were used. Only two out of six available pigs, 
including the selected donor animal, were found negative for both viruses. Nevertheless, PCMV 
was detected in the blood of the baboon. The titre of PCMV in the blood was above 3x104/
ml and analysis of its sequence confirmed that it was PCMV, but not baboon CMV. The data 
highlight a considerable risk of PCMV infection and call for regular screening of donor pigs 
applying the most sensitive detection methods.
ABBREVIATIONS
DPF: Designated Pathogen-Free; HEV: Hepatitis E Virus; 
IgG: Immunoglobulin G: PCMV: Porcine Cytomegalovirus; Spf: 
Specified-Pathogen Free; PLHV: Porcine Lymphotropic Herpes 
viruses.
INTRODUCTION
The shortage of human donor organs for transplantation has 
limited the treatment of patients with severe organ failure. As an 
alternative, xenotransplantation was developed, using pig cells, 
tissues and organs. The pig has attracted interest as transplant 
donor because of its size, partial physiological compatibility, 
breeding characteristics and the potential for genetic 
modifications. To overcome the hyperacute rejection induced by 
preformed anti-Gal antibodies and other immunological rejection 
processes, numerous genetically modified pigs were created to 
express human complement regulatory or other proteins and/or 
α 1,3-galactosyltransferase knockouts(GalT-KO) (for review see 
[1]. 
Transplantation of pig cells, tissues and organs may be 
associated with transmission of porcine microorganisms, 
including viruses [2]. Whereas most porcine microorganisms 
with a zoonotic potential such as hepatitis virus E (HEV), 
porcine cytomegalovirus (PCMV), and porcine lymphotropic 
herpes viruses (PLHV-1, -2, -3) may be eliminated by designated 
pathogen-free (DPF) breeding of the animals [3-5], porcine 
endogenous retroviruses (PERVs) cannot be eliminated because 
they are part of the genome of all pigs [6]. However, the potential 
risk posed by all these viruses for the human transplant recipient 
is still unknown. Here we report transmission of PCMV by 
orthotopic heart transplant from a genetically modified pig 
which was tested PCMV negative. Like in previously published 
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cases PCMV may be involved in the earlier transplant rejection 
and death of the recipient baboon [7,8]. 
PCMV belongs to the genus Roseolovirus in the subfamily 
Betaherpesvirinae in the Herpesviridae family [9]. The enveloped 
viral particles are 150–200 nm in diameter and the only one 
completely sequenced PCMV contain a 128,367 bp linear double-
stranded DNA genome with 79 open reading frames [9]. Pigs 
are frequently infected with PCMV. The virus causes generally 
mild disease in animals younger than six weeks. Infected adult 
pigs may not present with symptoms of disease and the virus 
remains latent and therefore difficult to detect. The primary site 
of virus replication in pigs is in the nasal mucous glands or the 
lachrymal glands and the virus can be recovered from nasal and 
ocular discharge [10]. Since the related human cytomegalovirus 
(HCMV) is an important cause of morbidity and mortality in 
human allotransplant recipients [11], it may be expected that 
PCMV has a similar effect. It is important to note that PCMV as 
Roseolovirus is closer related to the human herpes virus 6 (HHV-
6) and HHV-7, than to HCMV (HHV-5). In two studies it has been 
shown that PCMV induced a significantly reduced transplant 
survival when PCMV-infected kidneys were transplanted in two 
non-human primate species, baboons and cynomolgus monkeys 
[7,8]. In another case, in addition to the transmission of PCMV the 
baboon cytomegalovirus was activated also in the recipient [12], 
however, in all these cases it remained unclear, whether PCMV 
was able to infect cells of the recipient.
Recently we reported a multi organ failure in a baboon after 
orthotopic transplantation of a heart from a triple genetically 
modified pig and showed that the baboon was not infected with 
HEV [13]. Here we concentrated for the above mentioned reasons 
on PCMV. In addition, we confirmed the absence of HEV in the 
transplanted baboon by more sensitive methods in comparison 
to the first analysis.
MATERIALS AND METHODS
Animals and treatment
Six candidate pigs (Sus scrofa) were available for 
transplantation. They were all triple genetically modified, all 
crossbreds of German Landrace and Large White, with a GalT-KO, 
expressing human CD46 and human thrombomodulin (Revivicor, 
Blacksburg, VA, USA and Institute for Molecular Animal Breeding 
and Biotechnology, Faculty of Veterinary Medicine, LMU, 
Munich, Germany). They were analysed for virus infections. The 
transplant recipient, a 4 years old male baboon, was treated with 
anti-CD20mAb (19 mg/kg, rituximab, Roche, Basle, Switzerland, 
days -7, 0, +7, +14), anti-CD40mAb (50 mg/kg , 2C10R4, Mass 
Biologics, Boston, MA, USA, days -1, 0, +3, +7, +10, +14, +19, later 
weekly), and anti-thymocyte globulin (ATG, 5 mg/kg, Fresenius/
Neovii Biotech, Gräfelfing, Germany, days -2 and -1). Continuous 
immunosuppressive treatment included mycophenolate mofetil 
(40mg/kg/d, CellCept, Roche Pharma AG, Basle, Switzerland) 
and methylprednisolone (10 mg/kg/d, urbason, Sanofi-
Aventis, Paris, France). Immunosuppression was performed as 
described by Mohiuddin et al. [14,15], with slight modifications. 
Prophylactic anti-herpes virus and anti-bacterial treatment was 
performed using ganciclovir (5mg/kg/d, given intravenously, 
Cymeven, Roche Pharma AG, Basel, Switzerland) and cefuroxim 
(50mg/kg/d, Fresenius, Bad Homburg, Germany, until day 5) 
given during the entire experiment. The animal experiment was 
approved by the Goverment of Upper Bavaria, Munich, Germany 
(reference number 55.2-1-54-2532-184-2014).
Western blot analysis
To screen for immunoglobulins G (IgG) against HEV, a 
Western blot analysis was performed using two recombinant 
HEV proteins as described [16]. First, a recombinant genotype 
3 (GT3) ORF 2 - HEV antigen (aa 326-608, GT3-Ctr, 32 kDa) 
containing the entire immunodominant region and second, a 
recombinant 44.5 kDa protein with a glutathione-S transferase 
(GST) tag fused to the ORF2 fragment (aa 452-617, Prospec, Ness 
Ziona, Israel) (Figure 1A). Electrophoresis of the antigens was 
performed in precast preparative Tris-Glycine 4%–20% gradient 
SDS-PAGE gels using SDS Tris-Glycine sample buffer (Novex, Life 
Technologies Carlsbad, CA, USA). Proteins were transferred for 
2 h at 40ºC (46V) onto supported nitrocellulose (GE Healthcare 
Amersham, Protran, 0. 22 µm, BA83). The membrane was stained 
with 0.1% Ponceau red to control the efficacy of transfer and 
cut into strips. The load of antigens per strip was estimated at 
300 ng. The membranes were blocked with 6% dry milk in PBS 
with 0.1% Tween 20 (blocking buffer) overnight at 40ºC. Strips 
were treated with sera diluted 1:150 in blocking buffer for 2 h at 
room temperature. Goat anti-pig IgG (Abcam, Cambridge, UK) or 
goat anti-human IgG alkaline phosphatase conjugated antibodies 
(Sigma-Aldrich, USA) were taken 1:1000 in blocking buffer. 
Reaction was developed using NBT (nitro-blue tetrazolium 
chloride) - BCIP (5-bromo-4-chloro-3’-indolyphosphate 
p-toluidine salt) substrate (Promega, Madison, WI, USA). Sera 
from a HEV-infected and non-infected pigs were used as positive 
and negative controls, respectively.
RNA and DNA isolation
To screen for HEV, RNA was isolated twice from 100 µl of 
blood and 100 µl sera using RNAeasy Blood and Tissue kit as 
recommended by the manufacturer (Qiagen GmbH, Hilden, 
Germany). To screen for PCMV by nested PCR, DNA was extracted 
from sera and blood of the pigs using two DNA extraction kits: DN 
easy Blood and Tissue kit (Qiagen GmbH, Hilden, Germany) and 
ZR viral DNA kit (Zymo Research Corp., Irvine, CA, USA).DNA and 
RNA were quantified using a NanoDrop ND-1000 (Thermo Fisher 
Scientific Inc., Worcester, MA, USA).
Nested PCR analysis
To detect PCMV, a nested PCR was performed targeting the DNA 
polymerase (DNApol) gene using the following pairs of primers for 
PCR amplification: F1 (nt. 63-81) 5’- ACGGGGATCGACGAGAAAG,), 
R1 (nt. 412-388) 5’-TCTAGACGACAGGACATTGTTGAT, F2 (182-
201) 5’- GAAGAGAAAGGAAGTGAAGG, and R2 (nt. 387-368) 
5‘- GTCACTCGTCTGCCTAAGC (nt. positions corresponding to 
GenBank AJ222640) [17]. The reaction was performed using the 
GoTaq hot start green master mix x2 and the parameters of the PCR 
were as recommended by the supplier (Promega, Madison, WI, 
USA). 120 ng of DNA from sera and blood were tested in a 40 cycle 
PCR using the following parameters: denaturation was at 95ºC for 
30 sec, the annealing step at 58oC for 30 sec and extension at 70ºC 
for 40 sec. One microliter from the first reaction was taken for the 
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35 cycles nested PCR using the same denaturation parameters 
and 54oC as annealing temperature for 30 sec and extension at 
70ºC for 30 sec. The conditions of this extended conventional 
PCR targeting PCMV DNApol were mostly the same as described 
above (with exception of the extension time). The following 
primers were used: F1 ext. (nt.1695-1717,GenBank AJ222642)5‘-
GGACAGCAGAGAAGGGTGTTCAC-3’ and R1 ext. (nt.2276-2254, 
GenBank AJ222642)5’-GTTGATAAAGTCACTCGTCTGCC-3’, the 
annealing temperature was 54oC and extension was carried outat 
70ºC for 45 sec.
The detection limit of the conventional one round PCR was 15 
copies, that of the extended conventional PCR - 25 copies and the 
limit of the nested PCR were 5 copies, as estimated using serial 
dilution of the reference plasmid with a known copy number. 
Real-time PCR analysis
To screen for HEV, a real-time RT-PCR targeting the orf 2 of 
the HEV was performed using primers, a probe and parameters 
as described for a diagnostic real-time RT-PCR system [18].
To screen for PCMV, a real-time PCR with a detection limit 
of 2-5 copies was performed using SensiFast probe no ROX 
one-step kit according to supplier recommendations (Bioline 
GmbH, Germany). 60 ng of DNA were used for testing. Reaction 
mixture contained 400 nM of both primers Fr-t (nt. 279-297) 
5’- AATGCGTTTTACAACTTCACG and Rr-t (nt. 382-361) 5’- 
CTGAGCATGTCCCGCCCTAT, 100 nM of the probe (nt. 331-350), 
5’- 6FAM-CTCTAGCGGCGTCCATCACC-BHQ in a final volume 
of 20 µl. The following conditions for amplification were used: 
denaturation at 95ºC for 5 min and 45 cycles of amplification 
with denaturation at 95oC for 10 sec, annealing at 59oC for 20 sec 
and extension at 60ºC for 25 sec. A standard curve was generated 
using serial dilutions of a reference plasmid with a known copy 
numbers [17]. Reporter fluorescence was measured using an 
Mx3005P Multiplex Quantitative PCR System (Stratagene, La 
Jolla, CA, USA). 
Cloning and sequencing
After electrophoresis on 1.2% agarose gel the amplicons 
were extracted using Invisorb Spin DNA extraction kit 
(STRATECmolecular, Berlin, Germany). The fragments were 
ligated into a pCR2.1-TOPO vector according to the protocol of 
the supplier (Invitrogen Life Technologies, USA). Z cells (Zymo 
Research, Irvine, CA USA) were transformed with the constructs 
for 25 min on ice and plated on LB agar/ampicillin dishes for 18 
hours at 37oC. Five colonies were collected and amplified in LB/
ampicillin medium overnight at 37ºC. Plasmids were isolated 
using Pure Yield plasmid miniprep system (Promega, Madison, WI, 
USA) and cleaved with EcoR1 to check for the inserts. The clones 
and amplicons were sequenced in both directions using primers 
from the cloning kit and BigDye terminator v.3.1sequencing kit 
(Applied Biosystems, Germany). 
Alignment and phylogenetic analysis
The Blast program (NCBI) was used for database search. 
The sequence alignments and neighbour-joining phylogenetic 
analyses were performed using software package Lasergene 
Version 10 (DNASTAR, Inc. Madison, USA).
RESULTS
Selection of the donor pig
The donor pig (#6) was selected for transplantation from six 
available pigs based on the finding that it was negative for the 
HEV genome,as reported [13]. Blood and sera from these six 
pigs were tested not only for HEV, but also for a PCMV infection. 
Screening for PCMV was performed using two newly established 
PCR diagnostic systems, a nested PCR and a real-time PCR [17]. 
Detection limits of the systems were 5 and 2 genome equivalents 
per reaction, respectively.
To detect HEV, RNA isolated from blood was analysed by real-
time RT-PCRThree animals (#1-#3)of sixwere found positive for 
HEV andthree (including donor pig #6) were negative (Table 
1). To confirm the previous results, in addition a Western blot 
analysis was performed using not one, but two recombinant 
HEV proteins as described [16]. A strong IgG response against 
two capsid protein of HEV was detected in sera of four animals 
(Figure 1A). It should be noted, that due to the age (22 days) of 
thepiglets#5 and #6 Table (1) their IgG immune response against 
Figure 1 Selection of the donor pig for orthotopic pig-to-baboon heart 
transplantation: Screening for HEV and PCMV in pigs 45 days before 
transplantation. A, Western blot analysis of the pig sera using two overlapping 
recombinant antigens (Prospec and GT3) corresponding to the core antigen 
of HEV (marked in blue, numbers of amino acids are indicated). The 
immunodominant region is marked yellow. Animal sera were tested at dilution 
1:100. “+” - serum from a HEV infected pig. ” –“ - serum from non-infected pig, 
GST, Glutathione S transferase Tag, His, Histidine Tag. B, Nested PCR targeting 
the DNApol region of the PCMV genome. DNA from sera of animals 1 to 6 was 
tested. Upper panel is the first PCR round; lower panel is the nested PCR. 
Positions of the amplicons are given by arrow heads. The donor animal used for 
transplantation is in bold.
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HEV was considered to be maternal. Such vertical transmissions 
of anti-HEV IgG from mother to offspring were reported [16]. 
DNA isolated from blood and sera of pigs was tested for PCMV 
using nested and real-time PCR. Three pigs (#1,#2,#4) of six 
were found positive in both tests (Figure 1B, Table 1). However, 
as shown by real-time PCR the virus titre in the infected animals 
was very low.Results of the genome equivalent estimation based 
on the serial titration of the reference are shown (Table 1). The 
pig #6 was negative for HEV and PCMV and therefore selected as 
donor animal. Although HEV and PCMV were detected in some 
of the available donor pigs, none of the animals showed clinical 
signs
Outcome of the transplantation
The heart from pig #6 (#3701 in [13]) was transplanted 
orthotopically into a baboon using a heart-lung machine as 
reported [13]. Despite the successful heart transplantation, the 
recipient baboon died 29 days after transplantation applying a 
non-toxic, especially non-liver toxic immunosuppression after a 
short history of liver failure. At day 28 the animal had 901 U/l 
alanine aminotransferase (ALT), 58 ng/ml troponin I and 1.1 mg/
dl bilirubin [13]. It is worth mentioning that the normal ALT level 
in humans and baboons is 10-40 U/l. More clinical and laboratory 
data are given in [13].
Lack of HEV transmission
Since a severe liver failure was observed in the recipient 
baboon, blood and sera from the animal were previously 
screened for HEV infection using a real-time RT-PCR and a 
Western blot analysis using a recombinant HEV GT3 protein as 
antigen [16]. Both tests were negative. Knowing that the level of 
HEV expression may be very low, the real-time RT-PCR analysis 
was repeated using newly extracted RNA from sera. The sample 
from donor pig #6 was found negative again (Table 1). The 
Western blot was also repeated, but in addition to the HEV GT3 
protein another recombinant HEV ORF2proteinwas used (Figure 
1A). Serum from donor pig reacted with both antigens, but no 
antibodies were found in the serum of the recipient baboon (not 
shown).Thus, the negative result ruling out a HEV infection of the 
recipient was confirmed.
Detection of PCMV in the baboon
DNA extracted from blood and serum from the baboon was 
tested for PCMV using recently established nested PCR and real-
time PCR diagnostic systems [17]. PCMV was detected already 
after the first step of conventional nested PCR indicating a virus 
load >100 genome equivalents per reaction (Figure 2A). Further 
on a real-time PCR quantification demonstrated that there were 
3 x 104 genome equivalents/ml blood of the recipient (Table 1). 
To confirm the porcine origin of the detected virus the amplicon 
obtained by conventional nested PCR was cloned, and sequenced. 
Neighbour-joining phylogenetic analysis of the viral sequences 
detected in the baboon indicated that they belong to the PCMV 
variant found in pigs from Germany (GenBank acc.AF258039), 
but not to the CMV from the Cercopithecidae family (Figure 2B). 
Table 1: Analysis of 6 genetically modified pigs and the baboon recipient for PCMV and HEV infections.
Animal Sex Age of the animal at day of sampling
PCMV nested PCR
sera            blood







Pig 1 F 60 days ++                ++ + (2-4) + (>100) Neg.
Pig 2 F 60 days ++                ++ + (2-4) + (<10) Neg.
Pig 3 M 55 days Neg.             Neg. Neg. + (>100) +
Pig 4 F 55 days ++                ++ + (10) Neg. +
Pig 5 M 22 days Neg.             Neg. Neg. Neg. +*
Pig 6 M 22 days Neg.             Neg. Neg. Neg. +*
Baboon M 4 years +                  + + (1.5x 103) Neg. Neg.
*Likely maternal antibodies; ** ge-genome equivalents
Figure 2 Detection of PCMV in the blood (bl.) and serum (s.) of the baboon 
after orthotopic pig-to-baboon transplantation of the heart of pig 6 by 
conventional PCR.A negative DNA control (c-) and a water control (neg) were 
included. To estimate the copy number of PMCV present in the animal, a 
dilution of the plasmid was tested (200 and 15 copies). B, Neighbour-joining 
phylogenetic analysis of the 350bp PCMV DNA polymerase sequence detected 
in the transplanted baboon. Two cloned sequences (cl. 1b and cl. 2b) and 
direct amplicons from sera (Ampl. s) and blood (Ampl. bl) were compared with 
published sequences from different PCMV and viruses isolated from rhesus 
monkeys (M. rhesus) and African green monkeys (AGM), the corresponding 
GenBank accession numbers are shown.
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baboon cl.3               ...........................A...................................T................
baboon cl.5               ...........................A...................................T................
Consensus                 ATCTGTGTTACTCTACCCTGATCTTAAATGACGAGGACGTGACGGGGATCGACGAGAAAGATATTCTGACGGTGCATGTA
---------+---------+---------+---------+---------+---------+---------+---------+
170       180       190       200       210       220       230       240
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany ................................................................................
DNApol (AF268039) Germany ................................................................................
DNApol (AF268040) Spain   ................................................................................
DNApol (HQ686081) China   ......A.........................................................................
DNApol (HQ113116) China   ....................................................T...........................
DNApol (AF268041) Japan   ................................................................................
baboon amplicon ................................................................................
baboon cl.3               ................................................................................
baboon cl.5               ................................................................................
Consensus AACAAGAATACCGTGTACAGGTTCGTTAGGAGCAGCGTCAGGGAGTCTATACTCGGCACGCTGCTGTCTAGATGGCTCAG
---------+---------+---------+---------+---------+---------+---------+---------+
250       260 270       280       290       300       310       320
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany .................................G..............................................
DNApol (AF268039) Germany ................................................................................
DNApol (AF268040) Spain   .................................G..............................................
DNApol (HQ686081) China   .................................G..............................................
DNApol (HQ113116) China   .............C.........T........................................................
DNApol (AF268041) Japan   .................................G................G.............................
baboonamplcon ................................................................................
baboon cl.3               ..................................................G.............................
baboon cl.5               ................................................................................
Consensus GAAGAGAAAGGAAGTGAAGGCGCGCATGAAACGCTGTGAGGACCCTATGTTGGCACTGATACTTGACAAGCAGCAGCTTG
---------+---------+---------+---------+---------+---------+---------+---------+
330       340       350       360 370       380       390       400
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany ................................................................................
DNApol (AF268039) Germany ................................................................................
DNApol (AF268040) Spain   ................................................................................
DNApol (HQ686081) China   ................................................................................
DNApol (HQ113116) China   ................................................................................
DNApol (AF268041) Japan   ................................................................................
baboon amplicon ................................................................................
baboon cl.3               ................................................................................
baboon cl.5               ................................................................................
Consensus                 CCCTCAAGGTGACGTGCAATGCGTTTTACGGCTTCACGGGAGCCGTGCACGGTCTGCTGCCGTGTCTCCCTCTAGCGGCG
---------+---------+---------+---------+---------+---------+---------+---------+
410       420       430       440 450       460       470       480
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany ................................................................................
DNApol (AF268039) Germany ................................................................................
DNApol (AF268040) Spain   ................................................................................
DNApol (HQ686081) China   ................................................................................
DNApol (HQ113116) China   ................................................G...............................
DNApol (AF268041) Japan   ................................................................................
baboon amplicon ................................................................................
baboon cl.3               ................................................................................
baboon cl.5               ................................................................................
Consensus                 TCCATCACCAGCATAGGGCGGGACATGCTCAGGCAGACG
---------+---------+---------+---------
490       500       510
---------+---------+---------+---------
DNApol (AJ222642) Germany .......................................
DNApol (AF268039) Germany .............................T.........
DNApol (AF268040) Spain   .......................................
DNApol (HQ686081) China   .......................................
DNApol (HQ113116) China   .......................................
DNApol (AF268041) Japan   .......................................
baboon amplicon .............................T.........
baboon cl.3               .............................T.........
baboon cl.5               .............................T.........
Consensus                 AGAAATATGCTGATACCCGACAAGATAGCGCCGCGGGAGACCGGCGAGGACGAGAGCTACAGGGGCGCCACTGTTCTGGA
---------+---------+---------+---------+---------+---------+---------+---------+
10        20        30        40        50        60        70        80
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany ................................................................................
DNApol (AF268039) Germany ................................................................................
DNApol (AF268040) Spain   ................................................................................
DNApol (HQ686081) China   ................................................................................
DNApol (HQ113116) China   .............................................................A..................
DNApol (AF268041) Japan   ................................................................................
baboon amplicon ...G....................G.......................................................
baboon cl.3               ...G............................................................................
baboon cl.5               ...G............................................................................
Consensus                 CCCACACGTGGGTTACTATGCTTCTCCXGTGATTGTCATGGATTTTGCCAGTTTGTACCCCAGCATAATGATAGCCAATA
---------+---------+---------+---------+---------+---------+---------+---------+
90        100       110       120       130       140       150       160
---------+---------+---------+---------+---------+---------+---------+---------+
DNApol (AJ222642) Germany ...........................G........T...........................................
DNApol (AF268039) Germany ...........................A....................................................
DNApol (AF268040) Spain   ...........................G........T...........................................
DNApol (HQ686081) China   ...........................R........T....................T......................
DNApol (HQ113116) China   ...........................G.............................T......................
DNApol (AF268041) Japan   ...........................G........T...........................................
Figure 3 Alignment of an extended PCMV fragment detected in the blood of the transplanted baboon with corresponding PCMV DNApol sequences from the GenBank. 
In addition to the amplicon, two clones (cl. 3 and cl.5) were sequenced. The acccession numbers are given in brackets and the countries of theorigin are indicated.
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As shown, the sequences of the DNApol regions of PCMV and CMV 
from Cercopithecoidea family are sub-divided into two distinct 
clusters and that was well supported by bootstrap analysis. In 
fact, the PCMV detected in the transplanted baboon showed only 
42% of nucleotide identity with CMV from the Cercopithecoidea 
family. To confirm that the detected sequence was not the result 
of a cross-contamination of the baboon sample with a reference 
plasmid used in the laboratory, another conventional PCR was 
established which generated a 580 bp amplicon of the DNApol 
gene. Amplification was performed; the amplicon was cloned 
and sequenced. The results proved that the animal was infected 
with PCMV and revealed mismatches with the reference plasmid 
indicating that the sample was not cross-contaminated (Figure 
3).
DISCUSSION
Here we demonstrate that a baboon recipient of a pig heart 
was infected with PCMV as a consequence of the xenotransplant, 
although the donor pig was virus negative when blood was tested 
using sensitive PCR methods. Obviously PCMV was replicating in 
the donor pig at a very low level and replication was considerably 
enhanced in the immunosuppressed recipient baboon.
Although the donor pig was a triple genetically modified 
animal with a GalT-KO and expressing hCD46 and human 
thrombomodulin, and although it was found negative when 
tested for PCMV using ultrasensitive detection methods, the 
baboon recipient died 29 days after transplantation. The 
immunosuppression applied was non liver toxic. Ganciclovir 
was given as a standard procedure, but it did not interfere 
with virus replication. This correlates well with previous data 
showing that ganciclovir which is highly effective in inhibition 
the replication of HCMV, is less effective against PCMV [19]. 
It remains unclear whether the PCMV infected baboon cells or 
whether its replication was restricted to the transplanted pig 
organ. The species-restriction of PCMV is under discussion. 
Whereas some authors were unable to infect human cells with 
PCMV [20], others demonstrated infection and expression of 
viral proteins in primary human fibroblasts [21]. We did not test 
organs from the deceased animal by PCR-based methods because 
these methods will not allow discriminating whether PCMV is 
associated with pig cell or baboon cells. The only method which 
could discriminate is immunohistochemistry; however there are 
no PCMV-specific antibodies available. 
Although this is only a case report, the picture observed 
here is in line with previous reports demonstrating a reduced 
survival time of pig kidney transplants which were derived from 
PCMV positive donor pigs [10,11]. In the first report, kidneys 
from GalT-KO animals were transplanted into baboons [11]. The 
animals had a survival time of 48.3 days when PCMV was absent, 
and 14.1 days when the kidney came from animals infected 
with PCMV. When kidneys were taken from pigs which had 
been derived from PCMV-positive pigs by Caesarean delivery, 
a survival time of even 53 days was obtained, indicating that 
Caesarean delivery is an effective strategy to remove PCMV from 
the pig herd. In the second report, cynomolgus monkeys received 
GalT-KO kidneys from pigs from two different sources, one 
source was the Massachusetts General Hospital (MGH)-Nippon 
Institute for Biological Sciences (NIBS), the other source was the 
Meji University [10]. Whereas the kidney from the MGH-NIBS 
pigs survived for 28.7 days on average, the transplants from 
the Meji pigs survived on average only for 9.2 days. The main 
difference between these two groups was the presence of PCMV 
in the Meji pigs, indicating the important influence of PCMV on 
transplant survival time. Thus, infection with PCMV may pose 
a significant risk for the human recipients after receiving pig 
cells, tissues or organs, especially when the recipient is treated 
with pharmaceutical immunosuppression. The mechanisms how 
PCMV caused an earlier organ failure were not investigated in 
details and remain unclear. 
To our knowledge this is the first case showing replication of 
PCMV in a non-human primate that received a transplant from 
a pig that was considered PCMV-negative after examination of 
blood and serum using highly sensitive PCR methods. 
The main lesson learned from this case is that PCMV may 
be not detected by a sensitive PCR in the DNA from blood and 
sera of donor pigs produced for xenotransplantation, and thus, 
it may pose a serious problem for the transplant recipient. Since 
the sensitivity of the PCR systems used in this study were close 
to PCR detection limit of one copy, thus, PCR detection cannot 
be significantly improved in future. However, the problem 
of virus detection can be partially solved by examination of 
different biological samples collected by non-invasive or low-
invasive methods (e.g., skin, urine, feces, anal swabs, saliva). 
These samples could be then tested using established diagnostic 
PCR systems. Preferentially, this screening should be performed 
soon after birth. Early testing is very important, since the data 
could be much more informative, than testing during fettering or 
later on in life, when the PCMV titer in blood is close or below 
the detection limits. It is known, that isolation of virus-negative 
animals is problematic. However, selected animals should be 
separated from the rest of the herd to form a “clean group” and 
re-tested shortly before the transplantation. If all animals in the 
herd are PCMV-positive, virus elimination should begin with 
Caesarean delivery [10,22], or early weaning [22,24]. In both 
cases the animals have to be isolated in order to prevent de novo 
infection. Such elimination programs have been suggested [4]. 
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